• Patrick E. McBride
  • Gail Underbakke


Dyslipidemias are disorders of lipoprotein metabolism, including lipoprotein overproduction or deficiencies, and are a major risk factor for atherosclerosis. They include primary disorders of lipoprotein metabolism and secondary disorders induced by behavioral or other metabolic causes. Approximately 25% of adults in the United States have total cholesterol (TCHOL) levels of 240 mg/dl or higher and nearly half have a TCHOL exceeding 200 mg/dl.1


National Cholesterol Education Program Lipoprotein Profile Bile Acid Sequestrant High Density Lipoprotein Level Familial Combine Hyperlipidemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Task Force on Cholesterol Issues. Cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 1990;81:1721–33.CrossRefGoogle Scholar
  2. 2.
    Expert Panel. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015–23.CrossRefGoogle Scholar
  3. 3.
    Austin MA. Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol 1989;129:249–59.PubMedGoogle Scholar
  4. 4.
    Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havell RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007–12,PubMedCrossRefGoogle Scholar
  5. 5.
    Oberman A, Kreisberg RA, Henkin Y. Principles and management of lipid disorders: primary care approach. Baltimore: Williams & Wilkins, 1992.Google Scholar
  6. 6.
    Kannel WB, Wolf P. Pulling it all together: changing the cardiovascular outlook. Am Heart J 1992;123:264–7.PubMedCrossRefGoogle Scholar
  7. 7.
    National Cholesterol Education Program Expert Panel. Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Am Fam Physician 1992;45:2127–36.Google Scholar
  8. 8.
    US Preventive Services Task Force. Screening for high blood cholesterol. Am Fam Physician 1990;41:503–13.Google Scholar
  9. 9.
    Pacala JT. The relation of serum cholesterol to risk of coronary heart disease: implications for the elderly. J Am Board Fam Pract 1990;3:271–82.PubMedGoogle Scholar
  10. 10.
    NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993;269:505–10.CrossRefGoogle Scholar
  11. 11.
    Genest J, Martin-Munley S, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85:2025–33.PubMedCrossRefGoogle Scholar
  12. 12.
    McBride P, Yeager D. A family approach to heart disease prevention. Fam Pract Recertif 1989;11:69–88.Google Scholar
  13. 13.
    Schaefer EJ, Levy RI. Pathogenesis and management of lipoprotein disorders. N Engl J Med 1985;312:1300–10.PubMedCrossRefGoogle Scholar
  14. 14.
    Scanu AM. Lipoprotein (a): a genetic risk factor for premature coronary heart disease. JAMA 1992;267:3326–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Kris-Etherton PM, Krummel D, Russell ME, et al. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc 1988;88:1373–400.PubMedGoogle Scholar
  16. 16.
    Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149–72.PubMedGoogle Scholar
  17. 17.
    Block G, Dresser CM, Hartman AM, Carroll MD. Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats. Am J Epidemiol 1985;122:27–40.PubMedGoogle Scholar
  18. 18.
    McBride P. The health consequences of cigarette smoking: cardiovascular diseases. Med Clin North Am 1992;76:333–53.PubMedGoogle Scholar
  19. 19.
    Lavie CJ, Gau GT, Squires RW, Kottke BA. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc 1988;3:605–21.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Patrick E. McBride
  • Gail Underbakke

There are no affiliations available

Personalised recommendations